Belvedere Trading
INSM icon

Belvedere Trading’s Insmed INSM Stock Holding History

Belvedere Trading’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-25,000
Closed -$1.68M – 805
2024
Q2 		$1.68M Buy
25,000
+6,600
+36% +$256K ﹤0.01% 92
2024
Q1 		$499K Buy
+18,400
New +$515K ﹤0.01% 159
2023
Q4 		– Sell
-10,700
Closed -$270K – 898
2023
Q3 		$270K Buy
+10,700
New +$245K ﹤0.01% 180

Other funds holding INSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Belvedere Trading's INSM Position: Q3 2024 in Review

Belvedere Trading sold out of Insmed (INSM) in Q3 2024, closing a stake of 4,624 shares — an estimated $310K sold.

Belvedere Trading first reported a position in INSM in Q3 2023 and held it in 3 quarters. The position peaked at $477K in Q1 2024. 413 funds tracked by Wall St. Rank hold INSM as of Q3 2024.

  • Belvedere Trading reported no remaining Insmed position as of Q3 2024 after selling out during the quarter.
  • Belvedere Trading sold 4,624 Insmed shares in Q3 2024, an estimated $310K.
  • Belvedere Trading first reported a position in Insmed in Q3 2023 and held it in 3 quarters.
  • Belvedere Trading's Insmed position peaked at $477K in Q1 2024.
  • 413 funds tracked by Wall St. Rank held Insmed as of Q3 2024.

Based on Belvedere Trading's 13F filing for Q3 2024, filed 30 Oct 2024.